Li HY - Search Results

1

Carboxyl-terminal modulator protein facilitates tumor metastasis in triple-negative breast cancer.

Lin CH, Lin WD, Huang YC, Chen YC, Loh ZJ, Ger LP, Lin FC, Li HY, Cheng HC, Lee KH, Hsiao M, Lu PJ. Lin CH, et al. Among authors: li hy. Cancer Gene Ther. 2023 Mar;30(3):404-413. doi: 10.1038/s41417-022-00559-x. Epub 2022 Nov 18. Cancer Gene Ther. 2023. PMID: 36400965 Free PMC article.

2

Synthesis of 2-styrylchromones as a novel class of antiproliferative agents targeting carcinoma cells.

Shaw AY, Chang CY, Liau HH, Lu PJ, Chen HL, Yang CN, Li HY. Shaw AY, et al. Among authors: li hy. Eur J Med Chem. 2009 Jun;44(6):2552-62. doi: 10.1016/j.ejmech.2009.01.034. Epub 2009 Feb 6. Eur J Med Chem. 2009. PMID: 19246129

3

Synthesis and antiproliferative evaluation of certain indeno[1,2-c]quinoline derivatives. Part 2.

Tseng CH, Tzeng CC, Yang CL, Lu PJ, Chen HL, Li HY, Chuang YC, Yang CN, Chen YL. Tseng CH, et al. Among authors: li hy. J Med Chem. 2010 Aug 26;53(16):6164-79. doi: 10.1021/jm1005447. J Med Chem. 2010. PMID: 20662543

4

WWOX suppresses prostate cancer cell progression through cyclin D1-mediated cell cycle arrest in the G1 phase.

Lin JT, Li HY, Chang NS, Lin CH, Chen YC, Lu PJ. Lin JT, et al. Among authors: li hy. Cell Cycle. 2015;14(3):408-16. doi: 10.4161/15384101.2014.977103. Cell Cycle. 2015. PMID: 25659037 Free PMC article.

5

Landscape of Pin1 in the cell cycle.

Lin CH, Li HY, Lee YC, Calkins MJ, Lee KH, Yang CN, Lu PJ. Lin CH, et al. Among authors: li hy. Exp Biol Med (Maywood). 2015 Mar;240(3):403-8. doi: 10.1177/1535370215570829. Epub 2015 Feb 7. Exp Biol Med (Maywood). 2015. PMID: 25662955 Free PMC article. Review.

6

MiR-193a-5p/ERBB2 act as concurrent chemoradiation therapy response indicator of esophageal squamous cell carcinoma.

Lin CH, Tsai CH, Yeh CT, Liang JL, Hung WC, Lin FC, Chang WL, Li HY, Yao YC, Hsu TI, Lee YC, Wang YC, Sheu BS, Lai WW, Calkins MJ, Hsiao M, Lu PJ. Lin CH, et al. Among authors: li hy. Oncotarget. 2016 Jun 28;7(26):39680-39693. doi: 10.18632/oncotarget.9444. Oncotarget. 2016. PMID: 27203740 Free PMC article.

7

CTMP, a predictive biomarker for trastuzumab resistance in HER2-enriched breast cancer patient.

Chen YC, Li HY, Liang JL, Ger LP, Chang HT, Hsiao M, Calkins MJ, Cheng HC, Chuang JH, Lu PJ. Chen YC, et al. Among authors: li hy. Oncotarget. 2017 May 2;8(18):29699-29710. doi: 10.18632/oncotarget.10719. Oncotarget. 2017. PMID: 27447863 Free PMC article.

8

miR-105/93-3p promotes chemoresistance and circulating miR-105/93-3p acts as a diagnostic biomarker for triple negative breast cancer.

Li HY, Liang JL, Kuo YL, Lee HH, Calkins MJ, Chang HT, Lin FC, Chen YC, Hsu TI, Hsiao M, Ger LP, Lu PJ. Li HY, et al. Breast Cancer Res. 2017 Dec 19;19(1):133. doi: 10.1186/s13058-017-0918-2. Breast Cancer Res. 2017. PMID: 29258605 Free PMC article.

9

A novel long non-coding RNA linc-ZNF469-3 promotes lung metastasis through miR-574-5p-ZEB1 axis in triple negative breast cancer.

Wang PS, Chou CH, Lin CH, Yao YC, Cheng HC, Li HY, Chuang YC, Yang CN, Ger LP, Chen YC, Lin FC, Shen TL, Hsiao M, Lu PJ. Wang PS, et al. Among authors: li hy. Oncogene. 2018 Aug;37(34):4662-4678. doi: 10.1038/s41388-018-0293-1. Epub 2018 May 14. Oncogene. 2018. PMID: 29755127

10

High-CLDN4 ESCC cells harbor stem-like properties and indicate for poor concurrent chemoradiation therapy response in esophageal squamous cell carcinoma.

Lin CH, Li HY, Liu YP, Kuo PF, Wang WC, Lin FC, Chang WL, Sheu BS, Wang YC, Hung WC, Cheng HC, Yao YC, Calkins MJ, Hsiao M, Lu PJ. Lin CH, et al. Among authors: li hy. Ther Adv Med Oncol. 2019 Sep 27;11:1758835919875324. doi: 10.1177/1758835919875324. eCollection 2019. Ther Adv Med Oncol. 2019. PMID: 31632466 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,273 results

Search Page